LGALS1 and lung carcinoma: Galectin-1, -3, -7, and -9 were found to be significantly elevated in lung cancer patients (p = 0.0002, p < 0.0001, p = 0.0071, and p = 0.0002, respectively) in Figure 1A–C,E.